Strongyloides infects the duodenum and jejunum, but its life cycle also includes migration through the lungs. Infection occurs when larvae
penetrate the skin of humans or are passed via the fecal-oral route. Strongyloidiasis is endemic throughout the tropics and subtropics, including rural areas of the southern USA. More than half of infected persons are asymptomatic. Acute symptoms of strongyloidiasis may include epigastric pain and tenderness, diarrhea, nausea, vomiting, constipation, and weight loss. Chronic infection may lead to glucose malabsorption and protein-losing enteropathy.
Maculopapular or urticarial eruptions may occur. Occasionally, larvae mature in the bronchial submucosa and produce chronic bronchitis and asthma. Immunosuppression may lead to an overwhelming hyperinfection that can be potentially fatal.
In uncomplicated infection, treatment with ivermectin (200 ug/kg/d x 2 days, adult dose) or thiabendazole (25 mg/kg bid, <3 g/day, for 2 days, adult dose) results in 80 to 90% cure. Side effects of thiabendazole are frequent and occasionally disabling. Patients with a history of Strongyloides stercoralis exposure should undergo several stool examinations and, if necessary, a string test or duodenal aspiration before receiving corticosteroids or other immunosuppressive therapy.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.